Literature DB >> 7865896

Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat.

P Sacerdote1, B Manfredi, M Bianchi, A E Panerai.   

Abstract

It is well known that a variety of stressors influence immune responses. The opioid peptide-beta-endorphin (BE) is deeply involved in stress responses, is synthesized in cells of the immune system, and participates in the modulation of immune function. We analyzed the ability of two different stress paradigms to modulate the beta-endorphin concentrations in the immune cells and the immune response in the rat. Two and 24 h after the exposure to inescapable intermittent footshock (1.6 mA, 60 Hz, 1 s, every 5 s for 20 min) the concentrations of beta-endorphin in splenocytes, peripheral blood mononuclear cells and lymph node cells were significantly increased. In contrast, the exposure to a continuous footshock for 3 min did not affect the concentrations of the opioid peptide. Similarly, phytohemoagglutinin-induced proliferation of splenocytes and natural killer activity were significantly impaired only after the exposure to intermittent footshock stress. On the contrary, plasma corticosterone levels were similarly elevated after both paradigms of stress. The pretreatment with the corticotropin-releasing hormone (CRH) receptor antagonist prevented both the stress-induced increase of immunocyte BE and immunosuppression. In conclusion, our data suggest that intermittent and continuous footshock stressors activate different neuroendocrine responses and that CRH plays a central role in mediating the immune effects of the intermittent footshock stress. The possible relationship between the beta-endorphin changes and immunosuppression is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865896     DOI: 10.1006/brbi.1994.1023

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

Review 1.  [Influence of anesthesia procedure on malignant tumor outcome].

Authors:  K Fukui; C Werner; G Pestel
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

2.  Endogenous opioids modulate allograft rejection time in mice: possible relation with Th1/Th2 cytokines.

Authors:  P Sacerdote; V E di San Secondo; G Sirchia; B Manfredi; A E Panerai
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 3.  Managing Pain in the Older Cancer Patient.

Authors:  Dylan Finnerty; Áine O'Gara; Donal J Buggy
Journal:  Curr Oncol Rep       Date:  2019-11-14       Impact factor: 5.075

Review 4.  To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.

Authors:  Norman C Peterson; Elizabeth A Nunamaker; Patricia V Turner
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

Review 5.  Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients.

Authors:  Alan David Kaye; Nayan Patel; Franklin Rivera Bueno; Brad Hymel; Nalini Vadivelu; Gopal Kodumudi; Richard D Urman
Journal:  Ochsner J       Date:  2014

6.  Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

Authors:  Marganit Benish; Inbal Bartal; Yael Goldfarb; Ben Levi; Roi Avraham; Amiram Raz; Shamgar Ben-Eliyahu
Journal:  Ann Surg Oncol       Date:  2008-04-09       Impact factor: 5.344

Review 7.  A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies.

Authors:  George J DeMarco; Elizabeth A Nunamaker
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

Review 8.  The Relationship Between Regional Anesthesia and Cancer: A Metaanalysis.

Authors:  Ravi K Grandhi; Samuel Lee; Alaa Abd-Elsayed
Journal:  Ochsner J       Date:  2017

Review 9.  Anesthetic techniques and cancer recurrence after surgery.

Authors:  Vincenzo Fodale; Maria G D'Arrigo; Stefania Triolo; Stefania Mondello; Domenico La Torre
Journal:  ScientificWorldJournal       Date:  2014-02-06

10.  Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-γ expression of T cells in vitro?: A prospective, randomized, double-blind study.

Authors:  Naibao Zhou; Zhijian Fu; Hao Li; Kaiguo Wang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.